Work

Therapeutic targeting of regulatory T cells in cancer

Year: 2022

Type: review

Source: Trends in cancer

DOI: 10.1016/j.trecan.2022.06.008

Authors: Feng Shan, Ashwin Somasundaram, Tullia C. Bruno, Creg J. Workman, Dario A.A. Vignali

Institutions: University of Pittsburgh, UPMC Health System, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

Language: English

Topic: T-cell and B-cell Immunology

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Astellas Pharma US, F-star Therapeutics, G1 Therapeutics, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases

Awards: SPORE in Skin Cancer, G9000028255, Melanoma and Skin Cancer Program SPORE, Cancer Center Support Grant, Synergies among inhibitory receptors in tolerance and disease, Structure, Function and Mechanistic Analysis of LAG3, Regulatory T cells and the tumor microenvironment

OpenAlex ID: W4285604883

FWCI: 4.794

Cites: 236

Cited by: 249

Related to: 10